| Literature DB >> 26810755 |
Niccoló Giaj-Levra1, Francesco Ricchetti1, Filippo Alongi1.
Abstract
Radiotherapy treatment continues to have a relevant impact in the treatment of nonsmall cell cancer (NSCLC). Use of concurrent chemotherapy and radiotherapy is considered the gold standard in the treatment of locally advanced NSCLC but clinical outcomes are not satisfactory. Introduction of new radiotherapy technology and chemotherapy regimens are under investigation in this setting with the goal to improve unsatisfactory results. We report how radiotherapy is changing in the treatment of locally advanced NSCLC.Entities:
Keywords: Altered fractionation; Dose escalation; Locally advanced; New technology; Non small cell lung cancer; Radiotherapy
Mesh：
Year: 2016 PMID： 26810755 DOI： 10.3109/07357907.2015.1114121
Source DB: PubMed Journal: Cancer Invest ISSN： 0735-7907 Impact factor: 2.176